Mangoceuticals, Common Valuation
| MGRX Stock | 2.37 0.14 5.58% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Mangoceuticals, Common secures a last-minute Real Value of USD2.28 per share. The latest price of the firm is USD2.37. Our model forecasts the value of Mangoceuticals, Common from analyzing the firm fundamentals such as Return On Equity of -1.08, operating margin of (13.05) %, and Shares Outstanding of 2.4 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mangoceuticals, Common's valuation include:
Price Book 0.4217 | Enterprise Value 5.6 M | Enterprise Value Ebitda (0.51) | Price Sales 6.9498 | Enterprise Value Revenue 6.4916 |
Overvalued
Today
Please note that Mangoceuticals, Common's price fluctuation is dangerous at this time. Calculation of the real value of Mangoceuticals, Common is based on 3 months time horizon. Increasing Mangoceuticals, Common's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mangoceuticals, Common is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mangoceuticals, Stock. However, Mangoceuticals, Common's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.37 | Real 2.28 | Hype 2.46 | Naive 2.32 |
The intrinsic value of Mangoceuticals, Common's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Mangoceuticals, Common's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Mangoceuticals, Common Stock helps investors to forecast how Mangoceuticals, stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mangoceuticals, Common more accurately as focusing exclusively on Mangoceuticals, Common's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mangoceuticals, Common's intrinsic value based on its ongoing forecasts of Mangoceuticals, Common's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mangoceuticals, Common's closest peers.
Mangoceuticals, Common Cash |
|
Mangoceuticals, Valuation Trend
Analysing the historical paterns of Mangoceuticals, Common's enterprise value and its market capitalization is a good way to estimate and gauge the value of Mangoceuticals, Common Stock over time and is usually enough for investors to make rational market timing decisions.
Mangoceuticals, Common Total Value Analysis
Mangoceuticals, Common Stock is now projected to have valuation of 5.63 M with market capitalization of 6.02 M, debt of 128.68 K, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mangoceuticals, Common fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.63 M | 6.02 M | 128.68 K |
Mangoceuticals, Common Investor Information
About 36.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mangoceuticals, Common recorded a loss per share of 6.45. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 16th of October 2024. Based on the analysis of Mangoceuticals, Common's profitability, liquidity, and operating efficiency, Mangoceuticals, Common Stock is not in a good financial situation at this time. It has a very high probability of going through financial hardship in November.Mangoceuticals, Common Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mangoceuticals, Common has an asset utilization ratio of 69.61 percent. This suggests that the Company is making USD0.7 for each dollar of assets. An increasing asset utilization means that Mangoceuticals, Common Stock is more efficient with each dollar of assets it utilizes for everyday operations.Mangoceuticals, Common Ownership Allocation
Mangoceuticals, Common Stock holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Mangoceuticals, Common Profitability Analysis
The company reported the previous year's revenue of 731.49 K. Net Loss for the year was (9.21 M) with profit before overhead, payroll, taxes, and interest of 4.85 K.About Mangoceuticals, Common Valuation
Our relative valuation model uses a comparative analysis of Mangoceuticals, Common. We calculate exposure to Mangoceuticals, Common's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mangoceuticals, Common's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 431.5 K | 240 K | |
| Pretax Profit Margin | (12.59) | (13.22) | |
| Operating Profit Margin | (12.60) | (13.23) | |
| Net Loss | (12.59) | (13.22) | |
| Gross Profit Margin | 0.59 | 0.46 |
Mangoceuticals, Common Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 21.4 M |
Mangoceuticals, Common Current Valuation Indicators
Valuation refers to the process of determining the present value of Mangoceuticals, Common Stock and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mangoceuticals, we look at many different elements of the entity such as Mangoceuticals,'s management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mangoceuticals, Common, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mangoceuticals, Common's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mangoceuticals, Common's worth.Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.